POSTER SESSION II
Monday, March 9, 2009 — 1:00 PM - 4:30 PM
Hynes CC - Exhibit Hall C/D
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
95
SALL4 Is a Novel Sensitive and Specific Diagnostic Marker for Testicular Germ Cell Tumors
(725)
D Cao, RW Allan, PA Humphrey - Washington University in Saint Louis, Saint Louis; University of Florida, Gainesville, FL
How Should Hilar Paratesticular Soft Tissue Invasion Be Staged in Germ Cell Tumors
(916)
A Yilmaz, T Cheng, F Elliott, K Trpkov - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada; Tom Baker Cancer Center, Calgary, AB, Canada; Calgary, AB, Canada
The Utility of Microscopic Findings and Immunohistochemistry in the Classification of Necrotic Testicular Tumors: A Study of 11 Cases
(831)
JS Miller, TK Lee, JI Epstein, TM Ulbright - Johns Hopkins Hospital, Baltimore, MD; Indiana University School of Medicine, Indianapolis, IN
Teratoma with Malignant Transformation in Adult Testis: 25-Years Experience at Istituto Nazionale Tumori of Milan
(734)
M Colecchia, A Necchi, N Nicolai, M Di Nicola, L Piva, R Salvioni - Fondazione IRCCS Istituto Tumori Milano, Milan, Italy
CDX2 Expression in Yolk Sac Tumor of Testicular Origin
(718)
Z Bing, T Pasha, JE Tomaszewski, P Zhang - Hospitial of University of Pennsylvania, Philadelphia, PA
Expression of N-Cadherin in Yolk Sac Tumor of the Testis
(777)
DJ Heidenberg, M Grinkemeyer, DF Cameron, IA Sesterhenn - Armed Forces Institute of Pathology, Washington, DC
Rhabdomyomatous Tumors after Chemotherapy for Metastatic Testicular Germ Cell Tumors: A Study of 7 Cases
(733)
JA Clevenger, RS Foster, TM Ulbright - Indiana University School of Medicine, Indianapolis, IN
Lymphomas of the Genitourinary Tract: A Clinicopathologic Study of 40 Cases
(869)
SD Schniederjan, AO Osunkoya - Emory University School of Medicine, Atlanta, GA
TMPRSS2-ERG Gene Fusions in "Minimal" Prostatic Adenocarcinoma
(698)
R Albadine, M Latour, M Haffner, A Toubaji, T Lotan, J Epstein, GJ Netto - Johns Hopkins, Baltimore, MD
TMPRSS2-ERG Gene Fusion in Small Cell Carcinoma of the Prostate
(741)
JY Dancer, G Zuo, C Soto, P Troncoso, BA Czerniak, CC Guo - University of Texas MD Anderson Cancer Center, Houston, TX
TMPRSS2-ERG Fusion Is Frequently Observed in Gleason Pattern 3 Prostate Cancer in a Canadian Cohort
(743)
AD Darnel, CJ LaFargue, RT Vollmer, J Corcos, TA Bismar - McGill University and Jewish General Hospital, Montreal, QC, Canada; Weill Cornell Medical College, NY; VA and Duke University Medical Centers, Durham, NC; McGill University, Montreal, QC, Canada; University of Calgary, Calgary, AB, Canada
Prostate Cancer of Transitional Zone Lacks TMPRSS2-ERG Gene Fusion
(771)
CC Guo, G Zuo, D Cao, C Soto, P Troncoso, BA Czerniak - University of Texas MD Anderson Cancer Center, Houston, TX
Persistence of Expression of the TMPRSS2:ERG Fusion Gene after Pre-Surgery Androgen Ablation Is Associated with Early PSA Relapse of Prostate Cancer
(842)
G Nesi, L Bonaccorsi, M Paglierani, C Krausz, M Carini, Y Fang, SC Jhanwar, G Forti, E Baldi, L Luzzatto - University of Florence, Florence, Italy; Memorial Sloan-Kettering Cancer Center, New York; Istituto Toscano Tumori, Florence, Italy
Frequency of ERG Rearrangement in a Swedish Hospital Based Biopsy Cohort
(885)
MA Svensson, S Perner, F Demichelis, G Helenius, PW Kantoff, SO Andersson, O Andren, MA Rubin - Weill Cornell Medical College, New York, NY; Orebro University Hospital, Orebro, Sweden; Harvard Medical School, Boston, MA; Dana-Farber Cancer Institute, Boston, MA
TMPRSS2-ERG Gene Fusion Defines a Metastatic Phenotype of Prostate Cancer
(854)
S Perner, M Svensson, R Hossain, J Day, J Groskopf, MD Hofer, R Kuefer, DS Rickman, MA Rubin - Weill Cornell Medical Center, New York, NY; Gen-Probe, Inc., San Diego, CA; University Hospital of Ulm, Ulm, Germany; Brigham and Women's Hospital, Boston, MA
TMPRSS2-ERG Gene Fusions Are Infrequent in Prostatic Ductal Adenocarcinomas
(813)
TL Lotan, A Toubaji, R Albadine, M Latour, M Herawi, AK Meeker, JI Epstein, GJ Netto - Johns Hopkins Hospitals, Baltimore, MD
Detection of TMPRSS2 Gene Deletions and Translocations in Carcinoma, Intraepithelial Neoplasia and Normal Epithelium of the Prostate by Direct Fluorescence In Situ Hybridization
(922)
S Zhang, B Pavlovitz, J Tull, Y Wang, C Fuller - SUNY Upstate Medical University, Syracuse, NY; College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, China
Splice Variants and Functions of TMPRSS2-ERG Fusion, a Common Genomic Alteration in Prostate Cancer
(764)
B Furusato, C Sun, A Dobi, Y Hu, R Thangapazham, A Mohamed, EJ Whitman, D Hawksworth, SH Tan, J Cullen, Y Chen, G Petrovics, T Sreenath, DG McLeod, S Srivastava, IA Sesterhenn - Armed Forces Institute of Pathology, Washington, DC; Walter Reed Army Medical Center, Washington, DC; Center for Prostate Disease Research, Rockville, MD
Comprehensive FISH Assessment Shows Association of PTEN Deletion with ERG Rearrangement during Prostate Cancer Development
(774)
B Han, R Mehra, N Palanisamy, AM Chinnaiyan, RB Shah - University of Michigan, Ann Arbor, MI
Worrisome and Atypical Features in Renal Oncocytoma: Clinicopathological Analysis of 76 Cases
(903)
D Uzer, A Yilmaz, T Bismar, K Trpkov - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada
Phosphorylation of Histone H2A.X Is a Specific Marker To Distinguish Oncocytoma from Chromophobe Renal Cell Carcinoma
(896)
M Tretiakova, H Al-Ahmadie - University of Chicago, Chicago, IL
Oncocytic Renal Neoplasms: An Immunohistochemical Study with an Emphasis on Mammalian Target of Rapamycin Related Proteins
(865)
SM Rohan, ME Dudas, A Gopalan, SW Fine, VE Reuter, SK Tickoo - Memorial Sloan Kettering Cancer Center, NY, NY
Analysis of Novel Immunohistochemical Markers with a Cluster Analysis Approach To Define an Optimal Panel for the Differential Diagnosis of Renal Epithelial Neoplasms with Eosinophilic Cytoplasm
(911)
MJ Wasco, JC Carvalho, J Siddiqui, LP Kunju, DG Thomas, RB Shah - University of Michigan, Ann Arbor, MI
Renal Oncocytomas with Atypical Features: A Clinicopathologic Analysis of 34 Cases
(748)
KM Dishongh, CM Quick, N Gokden - University of Arkansas for Medical Sciences, Little Rock, AR
High-Grade Non Invasive Papillary Urothelial Carcinoma of the Urinary Bladder: Clinical Outcome in a Single Academic Center Cohort
(830)
JS Miller, DA Fajardo, TK Lee, H Miyamoto, GJ Netto - Johns Hopkins, Baltimore, MD
Low-Grade Papillary Urothelial Carcinoma of the Urinary Bladder: Clinicopathologic Outcome Analysis in a Post WHO/ISUP Classification Single Academic Center Cohort
(834)
H Miyamoto, JS Miller, DA Fajardo, TK Lee, GJ Netto - Johns Hopkins, Baltimore, MD
Establishment of Laminin and Pankeratin Dual Immunostain for the Evaluation of Urothelial Carcinoma
(927)
DL Zynger, OM Radu, AV Parwani - University of Pittsburgh Medical Center, Pittsburgh, PA
Distribution of Smoothelin Expression in the Musculature of the Genitourinary Tract
(792)
S Khayyata, M Dudas, SM Rohan, A Gopalan, SW Fine, VE Reuter, SK Tickoo - Memorial Sloan-Kettering Cancer Center, New York, NY
Immunohistochemical Screening for Lynch Syndrome in Patients with Urothelial Carcinoma of the Renal Pelvis and Ureter Does Not Correlate with Clinical Screening Parameters
(697)
I Aguilera-Barrantes, H Hampel, R Westman, WL Frankel, RE Jimenez - The Ohio State University, Columbus, OH; Mayo Clinic, Rochester, MN
MMR IHC in Upper Urinary Tract Urothelial Carcinoma
(913)
AL Wilson, WG Watkin, R Thornburg, M Morgan, KL Kaul - Evanston Hospital, NorthShore University HealthSystem, Evanston, IL
button next to any title to add to Itinerary Planner...
Add
